Jiangsu Nhwa Pharmaceutical Co Ltd

002262

Company Profile

  • Business description

    Jiangsu Nhwa Pharmaceutical Co Ltd is a drug manufacturer. The company is engaged in the manufacturing of APIs and dosages. The company markets its pharmaceutical products in four main categories: anesthetic drugs, such as midazolam injection and etomidate fat emulsion injection; psychiatric drugs, including risperidone tablets and related products; neurological drugs, such as gabapentin capsules; and bulk pharmaceuticals, including fenofibrate and miconazole nitrate. In addition, the company is also involved in the pharmaceuticals trading business.

  • Contact

    No. 31, Longhu West Road
    Enhua Technology Building
    Economic and Technological Development Zone
    Xuzhou221009
    CHN

    T: +86 51687767115

    https://www.nhwa-group.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    6,003

Stocks News & Analysis

stocks

Cheap ASX share may have more room to run

Shares are cheap despite rebounding share price, yet risks remain.
stocks

ASX listed media giant drives strong earnings growth

Digital growth drives earnings beat for media share.
stocks

ASX real estate platform outperforms yet questions remain

Valuation remains a key concern despite strong August reporting.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,412.6024.80-0.26%
CAC 408,714.9315.220.17%
DAX 4026,319.45179.320.69%
Dow JONES (US)54,036.93151.830.28%
FTSE 10010,901.0933.200.31%
HKSE25,881.84213.810.83%
NASDAQ26,690.62342.261.30%
Nikkei 22566,931.481,324.772.02%
NZX 50 Index13,845.7021.570.16%
S&P 5007,757.6447.680.62%
S&P/ASX 2009,220.8028.80-0.31%
SSE Composite Index3,948.648.600.22%

Market Movers